Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:BRTXQ NASDAQ:BTSG NASDAQ:GH NASDAQ:RDNT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBRTXQBioRestorative Therapies$1.45$1.56$0.00▼$0.06$2.38B102.3662.17 million shs78,996 shsBTSGBrightSpring Health Services$27.31+0.2%$22.88$14.03▼$28.43$4.83B2.272.87 million shs5.56 million shsGHGuardant Health$59.15+0.6%$54.45$20.14▼$68.00$7.33B1.462.17 million shs2.81 million shsRDNTRadNet$76.44-0.2%$64.97$45.00▼$93.65$5.89B1.54644,384 shs1.31 million shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBRTXQBioRestorative Therapies+1.40%-9.38%-3.65%-8.23%-17.14%BTSGBrightSpring Health Services+0.22%+3.25%+15.57%+22.63%+83.66%GHGuardant Health+0.60%+7.74%+1.11%+20.37%+135.85%RDNTRadNet-0.18%+3.28%+11.36%+38.40%+13.90%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBRTXQBioRestorative Therapies$1.45$1.56$0.00▼$0.06$2.38B102.3662.17 million shs78,996 shsBTSGBrightSpring Health Services$27.31+0.2%$22.88$14.03▼$28.43$4.83B2.272.87 million shs5.56 million shsGHGuardant Health$59.15+0.6%$54.45$20.14▼$68.00$7.33B1.462.17 million shs2.81 million shsRDNTRadNet$76.44-0.2%$64.97$45.00▼$93.65$5.89B1.54644,384 shs1.31 million shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBRTXQBioRestorative Therapies+1.40%-9.38%-3.65%-8.23%-17.14%BTSGBrightSpring Health Services+0.22%+3.25%+15.57%+22.63%+83.66%GHGuardant Health+0.60%+7.74%+1.11%+20.37%+135.85%RDNTRadNet-0.18%+3.28%+11.36%+38.40%+13.90%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBRTXQBioRestorative Therapies 0.00N/AN/AN/ABTSGBrightSpring Health Services 2.92Moderate Buy$27.10-0.77% DownsideGHGuardant Health 3.06Buy$58.24-1.55% DownsideRDNTRadNet 3.25Buy$76.800.47% UpsideCurrent Analyst Ratings BreakdownLatest BRTXQ, GH, RDNT, and BTSG Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/10/2025BTSGBrightSpring Health ServicesBank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$27.50 ➝ $31.009/8/2025BTSGBrightSpring Health ServicesDeutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetBuy$30.009/4/2025GHGuardant HealthBTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$65.00 ➝ $70.009/3/2025RDNTRadNetBarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$60.00 ➝ $79.009/3/2025RDNTRadNetTruist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$74.00 ➝ $81.008/18/2025RDNTRadNetZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold8/13/2025RDNTRadNetRaymond James FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingStrong-Buy$66.00 ➝ $75.008/11/2025RDNTRadNetMorgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeOverweight8/4/2025BTSGBrightSpring Health ServicesCowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy7/31/2025GHGuardant HealthScotiabankSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetSector Outperform$57.00 ➝ $60.007/31/2025GHGuardant HealthRaymond James FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$59.00 ➝ $61.00(Data available from 9/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBRTXQBioRestorative Therapies$110K21,613.25N/AN/A($0.68) per share-2.13BTSGBrightSpring Health Services$11.27B0.43$1.88 per share14.56$9.46 per share2.89GHGuardant Health$739.02M9.98N/AN/A($1.13) per share-52.35RDNTRadNet$1.83B3.21$3.48 per share21.99$15.31 per share4.99Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBRTXQBioRestorative Therapies-$12.52M-$1.07N/A∞N/AN/AN/AN/AN/ABTSGBrightSpring Health Services-$18.06M$0.3188.1033.300.460.55%9.29%2.64%11/7/2025 (Estimated)GHGuardant Health-$436.37M-$3.35N/AN/AN/A-49.93%N/A-28.95%11/5/2025 (Estimated)RDNTRadNet$2.79M-$0.20N/A144.23N/A-0.78%2.41%0.82%11/10/2025 (Estimated)Latest BRTXQ, GH, RDNT, and BTSG EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/10/2025Q2 2025RDNTRadNet$0.17$0.31+$0.14$0.43$488.06 million$498.23 million8/1/2025Q2 2025BTSGBrightSpring Health Services$0.19$0.22+$0.03$0.13$2.99 billion$3.15 billion7/30/2025Q2 2025GHGuardant Health-$0.52-$0.44+$0.08-$0.80$211.19 million$232.09 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBRTXQBioRestorative TherapiesN/AN/AN/AN/AN/ABTSGBrightSpring Health ServicesN/AN/AN/AN/AN/AGHGuardant HealthN/AN/AN/AN/AN/ARDNTRadNetN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBRTXQBioRestorative TherapiesN/AN/AN/ABTSGBrightSpring Health Services1.431.761.34GHGuardant HealthN/A3.713.35RDNTRadNet0.912.002.00Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBRTXQBioRestorative TherapiesN/ABTSGBrightSpring Health ServicesN/AGHGuardant Health92.60%RDNTRadNet77.90%Insider OwnershipCompanyInsider OwnershipBRTXQBioRestorative Therapies12.20%BTSGBrightSpring Health Services3.40%GHGuardant Health6.10%RDNTRadNet5.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBRTXQBioRestorative Therapies71.64 billionN/ANot OptionableBTSGBrightSpring Health Services35,000177.15 million171.13 millionOptionableGHGuardant Health2,021124.71 million117.10 millionNot OptionableRDNTRadNet11,02176.92 million72.61 millionOptionableBRTXQ, GH, RDNT, and BTSG HeadlinesRecent News About These CompaniesInsider Selling: RadNet (NASDAQ:RDNT) EVP Sells 35,000 Shares of StockSeptember 19 at 8:28 PM | marketbeat.comTesting & Diagnostics Services Q2 Earnings: Guardant Health (NASDAQ:GH) is the Best in the BizSeptember 19 at 7:59 AM | msn.comRadNet (NASDAQ:RDNT) CEO Cornelis Wesdorp Sells 500 SharesSeptember 16, 2025 | marketbeat.comCornelis Wesdorp Sells 500 Shares of RadNet (NASDAQ:RDNT) StockSeptember 16, 2025 | insidertrades.comIntech Investment Management LLC Acquires 22,198 Shares of RadNet, Inc. $RDNTSeptember 15, 2025 | marketbeat.comInsider Selling: RadNet (NASDAQ:RDNT) COO Sells 10,000 Shares of StockSeptember 14, 2025 | marketbeat.comNorman Hames Sells 10,000 Shares of RadNet (NASDAQ:RDNT) StockSeptember 13, 2025 | insidertrades.comInsider Selling: RadNet (NASDAQ:RDNT) CEO Sells 500 Shares of StockSeptember 11, 2025 | insidertrades.comFred Alger Management LLC Raises Holdings in RadNet, Inc. $RDNTSeptember 11, 2025 | marketbeat.comAxiom Investors LLC DE Trims Stake in RadNet, Inc. $RDNTSeptember 10, 2025 | marketbeat.comRadNet, Inc. (RDNT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 10, 2025 | seekingalpha.comRoyal Bank of Canada Increases Stake in RadNet, Inc. $RDNTSeptember 10, 2025 | marketbeat.comAdage Capital Partners GP L.L.C. Sells 27,655 Shares of RadNet, Inc. $RDNTSeptember 9, 2025 | marketbeat.comRadNet, Inc. to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9th, 2025September 8, 2025 | globenewswire.comPunch & Associates Investment Management Inc. Raises Holdings in RadNet, Inc. $RDNTSeptember 8, 2025 | marketbeat.comAlyeska Investment Group L.P. Acquires 712,270 Shares of RadNet, Inc. $RDNTSeptember 6, 2025 | marketbeat.comBarclays Raises RadNet (NASDAQ:RDNT) Price Target to $79.00September 5, 2025 | marketbeat.comTruist Financial Forecasts Strong Price Appreciation for RadNet (NASDAQ:RDNT) StockSeptember 5, 2025 | marketbeat.com1 High-Flying Stock for Long-Term Investors and 2 We AvoidSeptember 4, 2025 | finance.yahoo.comRadNet price target raised to $81 from $74 at TruistSeptember 3, 2025 | msn.comRadNet price target raised to $79 from $60 at BarclaysSeptember 3, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesTake Profits Now: 3 Overbought Stocks Primed for a PullbackBy Dan Schmidt | August 25, 2025NVIDIA Stock Could Pull Back in September, But Don’t Bet on ItBy Thomas Hughes | August 28, 2025Snowflake’s Snowballing Business and Robust Stock Price OutlookBy Thomas Hughes | August 28, 20253 Reasons Salesforce Is a Bargain Right NowBy Sam Quirke | August 22, 20253 Tariff-Proof Retailers Making New All-time HighsBy Dan Schmidt | September 1, 2025BRTXQ, GH, RDNT, and BTSG Company DescriptionsBioRestorative Therapies OTCMKTS:BRTXQ$1.45 0.00 (0.00%) As of 09/19/2025BioRestorative Therapies, Inc. develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company's two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders. The BRTX-100 utilizes proprietary technology and involves collecting a patient's bone marrow, isolating and culturing stem cells from the bone marrow, and cryopreserving the cells. In an outpatient procedure, BRTX-100 is to be injected by a physician into the patient's damaged disc and treatment is intended for patients whose pain has not been alleviated by non-invasive procedures and who potentially face the prospect of surgery. The company have received authorization from the Food and Drug Administration to commence a Phase 2 clinical trial using BRTX-100to treat persistent lower back pain due to painful degenerative discs. The company is also developing Metabolic Program (ThermoStem), a cell-based therapy in preclinical stage to target obesity and metabolic disorders using brown adipose (fat) derived stem cells to generate brown adipose tissue (BAT). In addition, the company provides investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; and a research agreement with Pfizer, Inc. and the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. BioRestorative Therapies, Inc. was incorporated in 1997 and is based in Melville, New York. On March 20, 2020, BioRestorative Therapies, Inc., filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Eastern District of New York.BrightSpring Health Services NASDAQ:BTSG$27.31 +0.06 (+0.22%) Closing price 09/19/2025 04:00 PM EasternExtended Trading$27.64 +0.34 (+1.23%) As of 09/19/2025 05:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.BrightSpring Health Services, Inc. operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It serves patients through clinical providers and pharmacists. The company was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. BrightSpring Health Services, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky.Guardant Health NASDAQ:GH$59.15 +0.35 (+0.60%) Closing price 09/19/2025 04:00 PM EasternExtended Trading$59.06 -0.09 (-0.15%) As of 09/19/2025 07:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.RadNet NASDAQ:RDNT$76.44 -0.14 (-0.18%) Closing price 09/19/2025 04:00 PM EasternExtended Trading$76.46 +0.02 (+0.02%) As of 09/19/2025 06:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas FedEx Delivers Good News: The Bottom Is in for This Stock Tesla: 2 Reasons to Love Musk's $1B Buy, 1 Reason to Be Bearish Berkshire-Backed Lennar Slides After Weak Q3 Earnings Azure Leads While AI Excitement Fuels Microsoft Stock Caterpillar Stock Hits All-Time High—Is There More Room to Run? The Fed Cut Rates: What Now for the S&P 500 and Equity Markets? Darden Restaurants: A Textbook Buy-the-Dip Opportunity McDonald’s: New All-Time Highs Are Inevitable Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
